The marginal liver donor - an update

Transplant International

Volumn 21, Issue 8, 2008, Pages 713-724

  Attia, Magdy ^a   Silva, Michael A ^a   Mirza, Darius F ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Donor assessment; Initial poor function; Liver transplantation; Primary nonfunction; Split liver transplantation; Steatosis

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; IMMUNOGLOBULIN;

AGE DISTRIBUTION; BACTERIAL INFECTION; BILIARY TRACT DISEASE; BREAST CANCER; CADAVER DONOR; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; DISEASE TRANSMISSION; FATTY LIVER; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HUMAN; HYPERNATREMIA; HYPOTENSION; INFECTION RISK; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MYCOSIS; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME; VASCULAR DISEASE; VIROLOGY; AGE; BRAIN DEATH; DONOR; PATIENT SELECTION;

AGE FACTORS; BRAIN DEATH; FATTY LIVER; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; TISSUE DONORS;

EID: 57849152410     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00696.x     Document Type: Review

References (120)

1. Berlakovich GA. Clinical outcome of orthotopic liver transplantation. Int J Artif Organs 2002; 25: 935.
2. Neuberger J, McMaster P. Liver transplantation: indications. In: Blumgart LH, Fong Y, eds. Surgery of the Liver and Biliary Tract. London: WB Saunders, 2000: 2055-2069.
3. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480.
4. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86.
5. Schemmer P, Mehrabi A, Kraus T, et al. New aspects on reperfusion injury to liver-impact of organ harvest. Nephrol Dial Transplant 2004; 19(Suppl. 4): iv26.
6. Gracia CE, Bramhall S, Mirza DF. Use of marginal donors. Curr Opin Organ Transplant 2000; 5: 50.
7. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917.
8. Urena MAG, Gonzalez EM, Romero CJ, Delgrado FC, Monero Sanz C. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogast-roenterology 1999; 46: 1164.
9. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327.
10. Takeda Y, Arii S, Kaido T, et al. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation 1999; 67: 820.
11. Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastroin-test Liver Physiol 2001; 281: G382.
12. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 2557.
13. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157.
14. Chavin KD, Yang S, Lin HZ, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999; 274: 5692.
15. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999; 67: 195.
16. Teramoto K, Bowers JL, Kruskal JB, et al. In vivo microscopic observation of fatty liver grafts after reperfusion. Transplant Proc 1994; 26: 2391.
17. Brass CA, Roberts TG. Hepatic free radical production after cold storage: Kupffer cell-dependent and -independent mechanisms in rats. Gastroenterology 1995; 108: 1167.
18. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 1991; 13: 83.
19. Angele MK, Rentsch M, Hartl WH, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008; 195: 214.
20. Halon A, Patrzalek D, Rabczynski J. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Transplant Proc 2006; 38: 193.
21. Monsour Jr HP, Wood RP, Ozaki C, et al. Utility of pre-operative liver biopsy in live-related donor patients for liver transplantation. Transplant Proc 1994; 26: 138.
22. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409.
23. Todo S, Demetris AJ, Makowka L, et al. Primary non-function of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903.
24. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500.
25. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807.
26. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940.
27. Tekin K, Imber CJ, Atli M, et al. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation 2004; 77: 411.
28. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248.
29. Zamboni F, Franchello A, David E, et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001; 15: 53.
30. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 2005; 9: 295.
31. Salizzoni M, Franchello A, Zamboni F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486.
32. Cho JY, Suh KS, Kwon CH, et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl 2005; 11: 210.
33. Kwon CH, Joh JW, Lee KW, et al. Safety of donors with fatty liver in liver transplantation. Transplant Proc 2006; 38: 2106.
34. Soejima Y, Shimada M, Suehiro T, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 2003; 76: 344.
35. Cho JY, Suh KS, Lee HW, et al. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbi-lirubinemia during regeneration after living donor liver transplantation. Transpl Int 2006; 19: 807.
36. Wynne HA, Cope LH, Mutch E, Rawlins MD, Wood-house KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297.
37. Detre KM, Lombardero M, Belle S, et al. Influence of donor age on graft survival after liver transplantation-United Network for Organ Sharing Registry. Liver Transpl Surg 1995; 1: 311.
38. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation 1990; 49: 377.
39. Hoofnagle JH, Lombardero M, Zetterman RK, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 89.
40. Zhao Y, Lo CM, Liu CL, Fan ST. Use of elderly donors (>60 years) for liver transplantation. Asian J Surg 2004; 27: 114.
41. Borchert D, Glanemann M, Mogl M, Langrehr JM, Neuhaus P. Older liver graft transplantation, cholestasis and synthetic graft function. Transpl Int 2005; 18: 709.
42. Borchert DH, Glanemann M, Mogl M, Langrehr J, Neuhaus P. Adult liver transplantation using liver grafts from donors over 70 years of age. Transplant Proc 2005; 37: 1186.
43. Zapletal C, Faust D, Wullstein C, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 2005; 37: 1182.
44. De Carlis L, Colella G, Sansalone CV, et al. Marginal donors in liver transplantation: the role of donor age. Transplant Proc 1999; 31: 397.
45. Cameron AM, Ghobrial RM, Yersiz H, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748.
46. Alonso O, Loinaz C, Moreno E, et al. Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation. Transpl Int 2005; 18: 902.
47. Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7.
48. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248.
49. Garcia CE, Garcia RF, Gunson B, et al. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant 2004; 2: 183.
50. Sudhindran S, Pettigrew GJ, Drain A, et al. Outcome of transplantation using kidneys from controlled (Maastricht category 3) non-heart-beating donors. Clin Transplant 2003; 17: 93.
51. Kievit JK, Oomen AP, Heineman E, Kootstra G. The importance of non-heart-beating donor kidneys in reducing the organ shortage. EDTNA ERCA J 1997; 23: 11.
52. Reiner M, Cornell D, Howard RJ. Development of a successful non-heart-beating organ donation program. Prog Transplant 2003; 13: 225.
53. Reich DJ, Munoz SJ, Rothstein KD, et al. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation 2000; 70: 1159.
54. Muiesan P, Girlanda R, Jassem W, et al. Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg 2005; 242: 732.
55. Otero A, Gomez-Gutierrez M, Suarez F, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 2003; 76: 1068.
56. Manekeller S, Dobberahn V, Hirner A, Minor T. Liver integrity after warm ischemia in situ and brief preservation ex vivo: the value of aerobic post-conditioning. Cryobiology 2007; 55: 249.
57. Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791.
58. Hartwig MG, Patel V, Palmer SM, et al. Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation. Transplantation 2005; 80: 320.
59. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rak-ela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999; 68: 1058.
60. Ho JK, Harrigan PR, Sherlock CH, et al. Utilization of a liver allograft from a hepatitis B surface antigen positive donor. Transplantation 2006; 81: 129.
61. Saab S, Chang AJ, Comulada S, et al. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl 2003; 9: 1053.
62. Dodson SF, Issa S, Araya V, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997; 64: 1582.
63. Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003; 17: 308.
64. Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002; 73: 582.
65. Feng S, Buell JF, Cherikh WS, et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002; 74: 1657.
66. Ricchiuti A, Brunati A, Mirabella S, Pierini A, Franchello A, Salizzoni M. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience. Transplant Proc 2005; 37: 2569.
67. Gandhi MJ, Strong DM. Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007; 8: 267.
68. Buell JF, Trofe J, Sethuraman G, et al. Donors with central nervous system malignancies: are they truly safe? Transplantation 2003; 76: 340.
69. Buell JF, Beebe TM, Trofe J, et al. Donor transmitted malignancies. Ann Transplant 2004; 9: 53.
70. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation 2002; 73: 579.
71. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70: 1747.
72. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991; 23: 2629.
73. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 2: 7.
74. Penn I. Posttransplant malignancies. Transplant Proc 1999; 31: 1260.
75. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 2002; 74: 1409.
76. Morath C, Schwenger V, Schmidt J, Zeier M. Transmission of malignancy with solid organ transplants. Transplantation 2005; 80: S164.
77. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367: 225.
78. Cardillo M, De Fazio N, Pedotti P, et al. Split and whole liver transplantation outcomes: a comparative cohort study. Liver Transpl 2006; 12: 402.
79. Tucker ON, Heaton N. The 'small for size' liver syndrome. Curr Opin Crit Care 2005; 11: 150.
80. Oswari H, Lynch SV, Fawcett J, Strong RW, Ee LC. Outcomes of split versus reduced-size grafts in pediatric liver transplantation. J Gastroenterol Hepatol 2005; 20: 1850.
81. Wojcicki M, Silva MA, Jethwa P, et al. Biliary complications following adult right lobe ex vivo split liver transplantation. Liver Transpl 2006; 12: 839.
82. Broering DC, Topp S, Schaefer U, et al. Split liver transplantation and risk to the adult recipient: analysis using matched pairs. J Am Coll Surg 2002; 195: 648.
83. Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000; 232: 312.
84. Merion RM, Rush SH, Dykstra DM, Goodrich N, Freeman RB Jr, Wolfe RA. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 2004; 4: 1792.
85. Broering DC, Wilms C, Lenk C, et al. Technical refinements and results in full-right full-left splitting of the deceased donor liver. Ann Surg 2005; 242: 802.
86. Kim JS, Broering DC, Tustas RY, et al. Split liver transplantation: past, present and future. Pediatr Transplant 2004; 8: 644.
87. Kilic M, Seu P, Stribling RJ, Ghalib R, Goss JA. In situ splitting of the cadaveric liver for two adult recipients. Transplantation 2001; 72: 1853.
88. Zamir G, Olthoff KM, Desai N, Markxmann JF, Shaked A. Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation 2002; 74: 1757.
89. Azoulay D, Astarcioglu I, Bismuth H, et al. Split-liver transplantation. The Paul Brousse policy. Ann Surg 1996; 224: 737.
90. Azoulay D, Castaing D, Adam R, et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg 2001; 233: 565.
91. Crippin JS. Live donor liver transplantation: is it better than waiting? Gastroenterology 2007; 133: 2040.
92. Friend PJ, Imber CJ. Current status of liver transplantation. Methods Mol Biol 2006; 333: 29.
93. Graziadei IW. Living donor liver transplantation. Trop Gastroenterol 2007; 28: 45.
94. Pan GD, Yan LN. Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int 2006; 5: 345.
95. Kim DG, Moon IS, Kim SJ, Lee YJ, Lee MD. Effect of middle hepatic vein reconstruction in living donor liver transplantation using right lobe. Transplant Proc 2006; 38: 2099.
96. Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 2003; 237: 429.
97. Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006; 12: 920.
98. Figueras J, Busquets J, Grande L, et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation 1996; 61: 410.
99. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg 1999; 5: 421.
100. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med 1989; 321: 1014.
101. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651.
102. Cuende N, Miranda B, Canon JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplantation 2005; 79: 1445.
103. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989; 110: 1001.
104. Freeman RB, Giatras I, Falagas ME, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999; 68: 1107.
105. Satoi S, Bramhall SR, Solomon M, et al. The use of liver grafts from donors with bacterial meningitis. Transplantation 2001; 72: 1108.
106. Avolio AW, Agnes S, Chirico AS, Cillo U, Frongillo F, Castagneto M. Successful transplantation of an injured liver. Transplant Proc 2000; 32: 131.
107. Tucker ON, Girlanda R, Rela M, Heaton ND, Muiesan P. Successful outcome following transplantation of an injured liver from a nonheart beating donor. Transpl Int 2005; 18: 724.
108. Richards DA, Silva MA, Devall AJ. Electrochemical detection of free 3-nitrotyrosine: application to microdialysis studies. Anal Biochem 2006; 351: 77.
109. Richards DA, Silva MA, Murphy N, Wigmore SJ, Mirza DF. Extracellular amino acid levels in the human liver during transplantation: a microdialysis study from donor to recipient. Amino Acids 2007; 33: 429.
110. Silva MA, Richards DA, Bramhall SR, Adams DH, Mirza DF, Murphy N. A study of the metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation. Transplantation 2005; 79: 828.
111. Silva MA, Murphy N, Richards DA, et al. Interstitial lactic acidosis in the graft during organ harvest, cold storage, and reperfusion of human liver allografts predicts subsequent ischemia reperfusion injury. Transplantation 2006; 82: 227.
112. Silva MA, Mirza DF, Buckels JA, et al. Arginine and urea metabolism in the liver graft; a study using microdialysis in human orthotopic liver transplantation. Transplantation 2006; 82: 1304.
113. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of longterm outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005; 241: 905.
114. Weitz J, Koch M, Mehrabi A, et al. Living-donor kidney transplantation: risks of the donor-benefits of the recipient. Clin Transplant 2006; 20(Suppl. 17):13.
115. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
116. Mirza D, Gunson B, Da Silva RF, Mayer AD, Buckels JA, McMaster P. Policies in Europe on "marginal quality" donor livers. Lancet 1994; 344: 1480.
117. Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439.
118. Pomfret EA, Sung RS, Allan J, Kinkhabwala M, Melancon JK, Roberts JP. Solving the Organ Shortage Crisis: The 7th Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant 2008; 8: 745.
119. Avolio AW, Nardo B, Agnes S, et al. The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. Transplant Proc 2005; 37: 2584.
120. Briceno J, Padillo J, Rufian S, Solorzano G, Pera C. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Transpl Int 2005; 18: 577.